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Abstract: A novel design of a blood cleaner on-chip using an optical waveguide known as 
a PANDA ring resonator is proposed. By controlling some suitable parameters, the optical 
vortices (gradient optical fields/wells) can be generated and used to form the trapping tools in 
the same way as optical tweezers. In operation, the trapping force is formed by the   combination 
between the gradient field and scattering photons by using the intense optical vortices   generated 
within the PANDA ring resonator. This can be used for blood waste trapping and moves 
  dynamically within the blood cleaner on-chip system (artificial kidney), and is performed 
within the wavelength routers. Finally, the blood quality test is exploited by the external probe 
before sending to the destination. The advantage of the proposed kidney on-chip system is that 
the unwanted substances can be trapped and filtered from the artificial kidney, which can be 
available for blood cleaning applications.
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Introduction
Human kidneys are important excretory organs whose main functions are   maintaining 
the concentrations of various ions and other important substances constant, and the 
removal of wastes and other unwanted substances in the urine.1 One living human 
kidney has from 300,000 to over 1,000,000 nephrons,2 the number of which is related 
to birth weights.3 Each nephron comprises two parts, namely the glomerulus and the 
tubules. The glomerulus is comprised of capillary vessels and the blood plasma is 
filtered from the blood through the porous wall of the vessels.1
Chronic kidney disease (CKD) is a worldwide health problem increasing 
  dramatically in several countries.4,5 This is a key focus for health care planning, 
even in the developed world, in which many clinical organizations have been estab-
lished for the development of hemodialysis devices and methods.6–8 CKD and acute 
renal failure occurs when one suffers from gradual and usually permanent loss of 
kidney function over time and loses the ability to filter and remove waste and extra 
fluids from the body.
Hemodialysis is the process of removing waste products from the blood. This 
removal is normally done by the kidneys. If they are impaired and require treatment,9 
a dialysis machine (artificial kidney) can perform a similar function. The invention, 
manufacture, and implantation of the artificial kidney has been developed from the 
human organ.10–14 But artificial kidney dialysis has several disadvantages such as 
time wastage for blood dialysis (2–4 hours/visit), and the need for patients to visit 
the hospital every week (2–3 times/week). This has led researchers and inventors International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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to develop an implantable artificial kidney,15 which would 
increase convenience.
Optical trapping was first invented by Ashkin.16 It 
emerged as a powerful tool with wide-reaching applications 
in biology, physics, engineering, and medicine.17 The ability 
of optical trapping and manipulation of viruses, living cells, 
and bacteria without organelle damage18 by laser radia-
tion pressure has been demonstrated.19,20 This is specific to 
medicine and the application of nanotechnology. Lee et al21,22 
carried out a single red blood cell (RBC) deformability test, 
which was performed by using optical trapping plastic in a 
microfluidics chip, and a lab-on-a-chip for RBC transporta-
tion in the capillary network to circulate oxygen and carbon 
dioxide throughout the human body.23 The optical trap-
ping manipulation molecules in the liquid-core waveguide 
and its application to drug delivery has been reported by 
  Suwanpayak et al,24 in which a PANDA ring resonator is used 
to form, transmit, and receive the microscopic volume of the 
drug by controlling the ring parameters. This microscopic 
volume can be trapped and transported dynamically within 
the wavelength router or network.
Recently, the promising technique of microscopic volume 
trapping and transportation within an add/drop multiplexer 
have been reported both in theory25 and experiment,26 
respectively. Here the transporter is known as an optical 
tweezer. The optical tweezer generation technique is used 
as a powerful tool for the manipulation of micrometer-sized 
particles. To date, the usefulness of static tweezers is well 
recognized. Moreover, the use of dynamic tweezers is now 
also used in practical work.27–29 Schulz et al30 have shown 
the possibility of trapped atom transfer between two optical 
potentials. In principle, an optical tweezer uses the forces 
exerted by intensity gradients in the strongly focused beams 
of light to trap and move the microscopic volumes of mat-
ter by a combination of forces induced by the interaction 
between photons, due to the photon scattering effect. In 
application, the field intensity can be adjusted and tuned to 
the desired gradient field. The scattering force can then form 
the suitable trapping force. Hence, the appropriate force can 
be configured as the transmitter/receiver for performing long 
distance microscopic transportation.
In this paper, the dynamic optical tweezers/vortices are 
generated using dark soliton, bright soliton, and Gaussian 
pulse propagating within an add/drop optical multiplexer 
incorporating two nanoring resonators (PANDA ring 
  resonator). The dynamical behavior of soliton and   Gaussian 
pulse is well described by Tasakorn et al.31 By using the 
proposed system, the blood waste and unwanted substances 
can be trapped and transported (filtered) from the   artificial 
human kidney. Here, the required trapping tool sizes can be 
generated and formed for the specific blood waste molecules, 
where finally the clean blood can be obtained and sent to the 
destination via the through port. However, in practice, several 
sensors are required for environmental and blood quality 
control, which will be the topic of future investigation.
Theoretical background
In theory, the trapping forces are exerted by the intensity 
gradients in the strongly focused beams of light to trap and 
move the microscopic volumes of matter, in which the optical 
forces are customarily defined by the relationship below.32
  F
Qn P
c
m =   (1)
Here, Q is a dimensionless efficiency, nm is the refractive 
index of the suspending medium, c is the speed of light, and 
P is the incident laser power, measured using the specimen. 
Q represents the fraction of power utilized to exert force. 
For plane waves incident on a perfectly absorbing particle, 
Q is equal to 1. To achieve stable trapping, the radiation 
pressure must create a stable, three-dimensional equilibrium. 
Because biological specimens are usually contained in an 
aqueous medium, the dependence of F on nm can rarely be 
exploited to achieve higher trapping forces. Increasing the 
laser power is possible, but only over a limited range due to 
the possibility of optical damage. Q itself is therefore the 
main determinant of trapping force. It depends upon the NA 
(numerical aperture), laser wavelength, light polarization 
state, laser mode structure, relative index of refraction, and 
the geometry of the particle.
Furthermore, in the Rayleigh regime, trapping forces 
decompose naturally into two components. Since the elec-
tromagnetic field is uniform across the dielectric, particles 
can be treated as induced point dipoles. The scattering force 
is given by:32
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Here, σ is the scattering cross section of a Rayleigh sphere 
with radius r. 〈S〉 is the time averaged Poynting vector, n is 
the index of refraction of the particle, m = n/nm is the rela-
tive index, and k = 2πnm/λ is the wavenumber of the light. International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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The scattering force is proportional to the energy flux and 
points along the direction of the propagation of the incident 
light. The gradient field (Fgrad) is the Lorentz force acting on 
the dipole induced by the light field, and is given by:32
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is the polarizability of the particle. The gradient force is 
proportional and parallel to the gradient in energy density 
(for m . 1). The large gradient force is formed by the large 
depth of the laser beam. The stable trapping requires that 
the gradient force is in the – Z ˇ direction, which is against 
the direction of the incident light (dark soliton valley), and 
is greater than the scattering force. By increasing the NA, 
when the focal spot size is decreased, the gradient strength is 
increased.33 This happens within a tiny system, for instance, 
in nanoscale devices such as the nanoring resonator.
In our proposal, the trapping force is formed by using a 
dark soliton, in which the valley of the dark soliton is gen-
erated and controlled within the PANDA ring resonator by 
the control port signals. In operation, the optical tweezers 
can be trapped, transported, and stored within the PANDA 
ring resonator and wavelength router, which can be used to 
form the microscopic volume (molecule) transportation, thus 
allowing drug delivery via the waveguide.34 The manipulation 
of trapped microscopic volumes within the optical tweezers 
has been previously reported.25
Kidney on-chip manipulation
Microfluidics is a burgeoning field with important appli-
cations in areas such as medical devices, biotechnology, 
chemical synthesis, and analytical chemistry.34 The   Erickson 
lab35–40 research interests revolve around the study of 
micronanofluidics, including advancing flows, delivery, and 
implantable devices for living organs, in combination with 
optics.41–43 In this paper, we propose use of the optical trap-
ping tools in the application of blood manipulation dialysis 
(kidney dialysis) using the PANDA ring resonator systems 
by incorporating a wavelength router. In the blood cleaner 
  on-chip (Figure 1), we used the same theory of optical 
trapping and transportation technique for a blood dialysis 
system, in which the blood flows44,45 into the input port of 
the PANDA ring resonator, where the PANDA ring resonator 
system 1 (P1) works the same way as PANDA ring resonator 
system 2 (P2). The whole blood volume can be trapped and 
delivered in   liquid-core waveguide,46 of both high and low 
refractive indices, depending on the blood concentration, in 
which the whole blood concentration is 20% (n = 1.35), 40% 
(n = 1.35), 60% (n = 1.37).47,48
In operation, when blood flows in the waveguide 
channel,49,50 it is detected by a blood concentrate detector 
(versatile sensor, 3).51,52 Most important for blood dialysis 
is protein reabsorption into the renal artery, with the clean 
blood protein sensor53,54 placed to check the protein quality 
before release into the urine. The protein sensor will detect 
the blood protein component and help to regulate blood 
circulation until it is clean. Additionally, oxygen can be fed 
into the system via the add port (control) for high quality 
whole blood which is detected by wireless blood pressure55 
before delivery into the renal artery. In this case, the filtrate 
components are sodium (∼0.4 nm), chlorine (∼0.6 nm), and 
glucose (∼0.72 nm).56 Our system is integrated to be a single 
chip, which is equivalent to one Bowman’s capsule consisting 
of the glomerulus build-up in the capillary vessels.
A schematic of a blood cleaner is as shown in Figure 2, 
which is formed by PANDA ring resonators and liquid-
core waveguide as shown in Figure 3A. The waveguides 
were constructed by using different sizes and refractive 
indices as shown in Figure 3B, where in this case the blood 
cell index is 1.35. The different waveguides with sizes of 
5–8 µm and 1 nm were constructed for blood cells and 
proteins, respectively. The whole blood is input into the 
system via liquid-core 1 (input port), and the required trap-
ping molecules can be trapped and filtered by liquid-core 2. 
Finally, the unwanted substances are trapped and filtered 
via the drop ports. In   Figure 2A, the whole blood cells are 
input into the blood cleaner via the input ports (Ein), which 
is equivalent to the blood flow into the afferent artery as 
Figure 1 Schematic diagram of a proposed PANDA ring resonator.
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shown in Figure 2B. After the blood waste substances are 
filtered by the glomerulus, they are filtrated via the proximal 
tube. Finally, the clean blood is received via the efferent 
artery. The blood artery is replaced by the blood waveguide 
structure, which is formed by the liquid-core waveguide as 
shown in Figure 3, where the red blood cells (RBCs) with 
5–8 µm are input into the system via the input ports (liquid 
core 1), while the unwanted substances are trapped by the 
optical tweezers and filtered by the drop ports. Liquid core 2 
is used for the trapped proteins, in which the protein molecule 
size is 1 nm, which is smaller than the RBC, and therefore, 
the RCBs cannot be transported via the liquid-cores, which 
means only the unwanted substances are being trapped and 
transported in the liquid-core 2.
To form the optical trapping tools, a bright soliton with 
center wavelength at 1.50 µm, peak power 4 W, pulse 35fs 
is input into the system via the input port. The   coupling 
  coefficients are given as κ0 = 0.5, κ1 = 0.35, κ2 = 0.1, 
and κ3 = 0.35, respectively. The ring radii are Radd = 100 
and 75 µm, RR = 40 and 20 µm, and RL = 40 and 20 µm, 
respectively. To date, the evidence of a practical device with 
a radius of 30 nm has been reported by Tasakorn et al.31 
Aeff are 300 µm2 (r ≈ 9.77 µm) and 0.5 µm2 (r ≈ 400 nm). In 
this case, the dynamic tweezers (gradient fields) can be in 
the form of bright solitons, Gaussian pulses, and dark soli-
tons for trapping the required blood waste. In Figure 4, there 
are four different center wavelengths of tweezers generated, 
where the dynamical movements are a) |E1|2, b) |E2|2, c) |E3|2, 
d) |E4|2, e) through port, and f) drop port signals. In this case, 
the trapped molecules (blood waste) are filtered and obtained 
by the drop port. For instance, by using a whole blood index 
(n) of 1.35, the trapping probe widths of 20 nm at the wave-
length center at 1.60 µm are generated (see Figure 4A). More 
results in terms of coupling constants are shown in Figure 4B, 
where in this case the tunable trapping can be obtained. In 
practice, the more reliable device (blood cleaner on-chip) 
fabrication parameters are the ring resonator radii instead 
of coupling constants. More results of the optical trapping 
probes generated within the PANDA ring with different 
wavelengths are as shown in Figure 5A; the bright soliton is 
used as the control signal for the tunable result. The output 
optical tweezers of the through and drop ports with different 
coupling constants are as shown in Figure 5B, which forms the 
basis for the selected blood waste molecules. In application, 
the clean blood can be transported into the human body via 
the through port. The filtering molecules (urine) are received 
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Figure 4 results of the trapping tools with different A) sizes and wavelengths, B) tunable tweezers by coupling constant variation, where rad = 100 µm, rr = rL = 40 µm.
via the drop port. The advantage of the proposed system is 
that it can be fabricated on-chip and alternatively operated by 
a single device.57 The proposed system can be performed as 
a hemofiltration device, which is 90 µm in depth, 200 µm in 
width, and 300 µm in length. The unwanted substances can 
be trapped (filtrated) by the optical gradient field, and can 
be delivered via the control port (different wavelengths).58 
In operation, blood concentration does not affect the optical 
trapping ability, because the blood refractive index is slightly 
different, although it may affect the filtration speed.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Conclusion
We have shown that blood waste molecules can be trapped 
and filtered (transported) from the artificial blood cleaner 
(kidney), which can be performed on-chip. By utilizing the 
appropriate dark soliton input power, the required trapping 
tool sizes can be controlled and obtained, where finally 
the clean blood can be obtained before sending to the final 
destination (through port). Moreover, oxygen can be fed 
into the system via the control port, which is available for 
blood cleaning application. However, in practice, the blood 
cleaner on-chip system requires a specific environment, in 
which there are several sensors required to integrate into the 
system as shown in Figure 1, including bio-sensor, blood 
sensor, versatile sensor, protein sensor, and blood pressure 
sensor. Lastly, large molecules may be problematic for the 
generated trapping tool size. Therefore, the search for new 
media for guide pipes,59 for instance, nano tube materials, 
and sensors, will be the next focus of investigation.
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